SCHEMBL6004342

SCHEMBL6004342

CC(C)(C)OC(=O)Nc1ccc(C=O)cc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH5A1 P51649 1/20 0.48
ABAT P80404 1/20 0.48
MAPT P10636 7/20 0.46
VCAM1 P19320 1/20 0.44
ALDH1A1 P00352 6/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
HTT P42858 2/20 0.43
GLA P06280 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
ALDH3A1 P30838 1/20 0.42
ALDH1A3 P47895 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29952326 1.00 ALDH5A1 (0.48) ALDH5A1ABATMAPTVCAM1ALDH1A1
SCHEMBL18687359 0.86 AKR1C4 (0.46) ALDH5A1ABATMAPTNPC1RAB9A
SCHEMBL8231247 0.84 ALDH1A1 (0.58) MAPTALDH1A1KMT2ANPC1RAB9A
SCHEMBL31365089 0.84 ALDH1A1 (0.58) MAPTALDH1A1KMT2ANPC1RAB9A
SCHEMBL8469198 0.83 KCNMA1 (0.50) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL15160073 0.83 HTT (0.53) MAPTALDH1A1KMT2ANPC1RAB9A
SCHEMBL6478595 0.82 HPGD (0.44) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6004914 0.82 ALDH1A1 (0.54) ALDH5A1ABATMAPTALDH1A1MEN1
SCHEMBL21648181 0.82 HCAR3 (0.47) ALDH5A1ABATMAPTALDH1A1MEN1
SCHEMBL975856 0.82 ABCB1 (0.53) MAPTALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060167087-A1 Substituted aniline derivatives H. LUNDBECK A/S (DK) 2006-07-27 US disclosed
EP-1606247-A1 SUBSTITUTED ANILINE DERIVATIVES H. Lundbeck A/S (DK) 2005-12-21 EP disclosed
WO-2004080950-A1 SUBSTITUTED ANILINE DERIVATIVES H. LUNDBECK A/S (DK) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167087-A1 Substituted aniline derivatives CYP3A43, UGT2B7, CYP3A7 ALDH5A1 465/4885ABAT 174/4885MAPT 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.